Related Experiment Video
Updated: Jul 19, 2025
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.4K
Afterdischarges in myotonic dystrophy type 1
Li Yang1, Xiuying Chen2, Rui Wu3
1Electromyography Room, Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Jinan, Shandong, China. 340662606@qq.com.
Summary
Afterdischarges, a specific electrodiagnostic finding, are highly prevalent in myotonic dystrophy type 1 (DM1) but absent in other myotonic disorders. This suggests afterdischarges can aid in differentiating DM1 clinically.
Area of Science:
- Neurology
- Clinical Electrophysiology
Background:
- Electrodiagnostic testing, including electromyography, is crucial for screening myotonic dystrophy type 1 (DM1).
- Distinguishing DM1 from other myotonic disorders based solely on clinical presentation and myotonic discharges can be challenging.
Purpose of the Study:
- To investigate the diagnostic utility of afterdischarges in differentiating DM1 from other myotonic disorders.
- To analyze the occurrence rate of afterdischarges in DM1 patients compared to non-DM1 myotonia.
Main Methods:
- Retrospective analysis of electrodiagnostic findings from 33 patients with myotonic discharges.
- Patients were categorized into DM1 (n=20) and non-DM1 myotonia (n=13) groups based on gene testing.
- Afterdischarges were assessed through motor nerve conduction studies, F-waves, and repetitive nerve stimulation.
Main Results:
- Afterdischarges were detected in approximately 85% (17/20) of DM1 patients.
- No afterdischarges were observed in any of the non-DM1 myotonia patients (n=13).
- A statistically significant difference in afterdischarge occurrence was found between the groups (P < 0.01).
Conclusions:
- Afterdischarges show potential as a suggestive indicator for the clinical diagnosis of DM1.
- The presence of afterdischarges in DM1 may offer new insights into the underlying pathogenesis of the disease.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:29Relaxation of Skeletal Muscles
3.3K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.3K
01:15Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
01:28Disorders of the Skeletal Muscle
994
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
994
01:20Motor Unit Stimulation
1.6K
When the neuron of a motor unit fires an action potential, it triggers a series of events, leading to a twitch contraction in the muscle fibers. The process of excitation-contraction coupling is crucial in relaying the action potential to the muscle fibers.
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
1.6K
01:20Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K